Royalty Pharma plcRPRXNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$1.56B
Near historical average
Average (9y)
$1.51B
Historical baseline
Range
High:$2.75B
Low:$423.69M
CAGR
+6.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $1.56B | -17.5% |
| 2023 | $1.89B | +345.4% |
| 2022 | $423.69M | -70.4% |
| 2021 | $1.43B | -15.0% |
| 2020 | $1.68B | -38.9% |
| 2019 | $2.75B | +50.4% |
| 2018 | $1.83B | +12.8% |
| 2017 | $1.62B | +51.9% |
| 2016 | $1.07B | +24.0% |
| 2015 | $862.44M | - |